Maria Teresa Fierro

InstitutionUniversity of Turin
AddressTurin
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 97 publications over 25 distinct years, with a maximum of 14 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chiricozzi A, Talamonti M, De Simone C, Galluzzo M, Gori N, Fabbrocini G, Marzano AV, Girolomoni G, Offidani A, Rossi MT, Bianchi L, Cristaudo A, Fierro MT, Stingeni L, Pellacani G, Argenziano G, Patrizi A, Pigatto P, Romanelli M, Savoia P, Rubegni P, Foti C, Milanesi N, Belloni Fortina A, Bongiorno MR, Grieco T, Di Nuzzo S, Fargnoli MC, Carugno A, Motolese A, Rongioletti F, Amerio P, Balestri R, Potenza C, Micali G, Patruno C, Zalaudek I, Lombardo M, Feliciani C, Di Nardo L, Guarneri F, Peris K. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824. PMID: 34152613.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    2. Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Merli M, Tonella L, Ribero S, Fierro MT. Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit. Future Oncol. 2021 Mar; 17(7):759-761. PMID: 33533662.
      Citations: 2     Fields:    Translation:HumansCells
    3. Quaglino P, Fava P, Cariti C, Ortoncelli M, Aimetti M, Milan A, Dapavo P, Tonella L, Ribero S, Fierro MT. Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient. Eur J Dermatol. 2020 Dec 01; 30(6):747-748. PMID: 33262101.
      Citations: 1     Fields:    Translation:Humans
    4. Ribero S, Caliendo V, Picciotto F, Fierro MT, Quaglino P. COVID-19 infection and dermatologic surgery: management in a dermo-oncology center in a high-risk pandemic area. G Ital Dermatol Venereol. 2020 Oct; 155(5):684-685. PMID: 33084265.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Citations: 18     Fields:    Translation:Humans
    6. Pala L, Conforti F, Saponara M, De Pas T, Giugliano F, Omodeo Salè E, Jemos C, Rubatto M, Agostini A, Quaglino P, Fava P, Fierro MT, Queirolo P. Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19. Semin Oncol. 2020 10; 47(5):302-304. PMID: 32883537.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    7. Rozzo G, Ramondetta A, Fierro MT, Dapavo P, Ribero S. Moderate-to-severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak. Dermatol Ther. 2020 Jul; 33(4):e13680. PMID: 32447800.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    8. Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients? J Eur Acad Dermatol Venereol. 2020 Sep; 34(9):e440-e441. PMID: 32421876.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Quaglino P, Fava P, Brizio M, Marra E, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):1395-1396. PMID: 32426877.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health